Vote Scores
Filings read through

Invesco Nasdaq Biotechnology ETF proxy votes

Voting season: year to 30 June 2026. The filing read date describes collection, not the voting period. Read the management-mark denominator.

Tickers
IBBQ
SEC series number
S000072469
Filer
Invesco Exchange-Traded Fund Trust II
Fund family
Invesco
Season
year to 30 June 2026

Invesco Nasdaq Biotechnology ETF is a series of Invesco Exchange-Traded Fund Trust II. The filing reports 1,921 vote records for the series in the year to 30 June 2026. 222 of the 1,907 votes that the filing marks for or against management are against management (11.6%). The series reported 92 votes for and 103 votes against or abstaining on say-on-pay items in the year to 30 June 2026.

By vote records in the year to 30 June 2026, Invesco Nasdaq Biotechnology ETF was number 2,070 of 5,303 fund series with 500 or more vote records. The series had fewer than 500 vote records in the year to 30 June 2025, so this page gives no change from that year. In the year to 30 June 2026, category CORPORATE GOVERNANCE is 5.9% of its vote records. Across all fund series, it is 14.1%.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: votes counted and the against-management share for the year to 30 June 2026. All recorded changes

What this site holds for one fund

Each vote record on Form N-PX names the series that cast it. From these records the site keeps counts for each series and season.

The counts are votes, votes with and against management, say-on-pay votes, votes on proposals from security holders, and votes by category.

The site does not keep the vote of Invesco Nasdaq Biotechnology ETF at each company meeting. A company page shows the position of each fund family. A position is not the vote of each fund.

To see each vote of the series, open the filing of Invesco Exchange-Traded Fund Trust II on EDGAR.

The record, year to 30 June 2026

Vote records
1,921
With management
1,685
Against management: 11.6% of the votes marked
222
Say-on-pay support, 92 of 195 votes
47.2%
Support for proposals from security holders, 2 of 6 votes
33.3%
Invesco Nasdaq Biotechnology ETF beside its filer, its family and the median fund registrant, year to 30 June 2026
FigureThis seriesIts filerIts familyMedian fund registrant
Against-management share11.6%6.1%5.8%6.2%
Say-on-pay support47.2%84.2%82.0%91.6%
Support for proposals from security holders33.3%31.5%27.6%27.5%

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

Votes of Invesco Nasdaq Biotechnology ETF by category, year to 30 June 2026Category names as Form N-PX prints them. A vote can carry more than one category.
CategoryVotesForAgainstAgainst management
DIRECTOR ELECTIONS1,0571,008144.4%
SECTION 14A SAY-ON-PAY VOTES2329710345.3%
AUDIT-RELATED26926900.0%
SHAREHOLDER RIGHTS AND DEFENSES3300.0%
EXTRAORDINARY TRANSACTIONS181800.0%
CAPITAL STRUCTURE81661518.5%
COMPENSATION1501005032.9%
CORPORATE GOVERNANCE11410476.3%
ENVIRONMENT OR CLIMATE2110.0%
HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE1100.0%
DIVERSITY, EQUITY, AND INCLUSION2110.0%
OTHER SOCIAL ISSUES4220.0%

By season

Invesco Nasdaq Biotechnology ETF, each season on file
SeasonVote recordsAgainst managementSay-on-pay supportSupport for proposals from security holders
year to 30 June 20261,92111.6%47.2%33.3%
year to 30 June 20241,63819.1%58.2%42.9%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. Invesco Nasdaq Biotechnology ETF proxy votes, year to 30 June 2026. https://votescores.com/fund/s000072469-invesco-nasdaq-biotechnology-etf/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

What share of the votes of Invesco Nasdaq Biotechnology ETF is against management?
11.6% in the year to 30 June 2026: 222 of the 1,907 votes that the filing marks for or against management.
What does Invesco Nasdaq Biotechnology ETF report on say-on-pay votes?
The series reported 92 votes for and 103 votes against or abstaining on say-on-pay items in the year to 30 June 2026.
Does this page show the vote of Invesco Nasdaq Biotechnology ETF at one company?
Not on this site. The site keeps counts for each series. It does not keep the vote of a series at each meeting. The Form N-PX of Invesco Exchange-Traded Fund Trust II on EDGAR lists each vote with the series that cast it.
Is this the result of the meetings?
No. Form N-PX shows how the fund voted the shares it held. It does not show how other holders voted or the result of a meeting.

Provenance: SEC EDGAR, the Form N-PX of Invesco Exchange-Traded Fund Trust II (SEC filer number 1378872). The filer names the series that cast each vote. The filer wrote the filing. Ticker symbols come from the SEC mutual fund tickers file, matched on the series number. Filings read through .